Search results
Author(s):
Patrick W Serruys
Added:
2 years ago
CRT 2024 — Prof Patrick W Serruys (National University of Ireland, Galway, US) joins us to discuss learning from the SYNTAX trial.The SYNTAX trial is a randomized controlled trial designed to evaluate the efficacy and safety of percutaneous coronary intervention (PCI) with polymer-based paclitaxel-eluting TAXUS stents versus coronary artery bypass grafting (CABG) in patients with complex coronary…
View more
Added:
8 months ago
Source:
Transcatheter Academy
While clinical trials typically report average health outcomes at specific time points, a new secondary analysis of the ISCHEMIA trial has delved into the individual patient journeys of angina symptoms over time. The study identified six distinct patterns of angina trajectories, revealing that an initial invasive strategy is associated with more favourable symptom pathways compared to a…
View more
Author(s):
Armin Arbab-Zadeh
,
Michelle Graham
,
Hector M Garcia-Garcia
,
et al
Added:
8 months ago
Left Main Coronary Artery Intervention
Author(s):
Duy Cao Phuong Le
,
Hoa The Bui
,
Quan Duy Vo
Added:
2 years ago
Original Research
Coronary Calcification: From Pathophysiology to Outcomes
Author(s):
Angela McInerney
,
Seán O Hynes
,
Nieves Gonzalo
Added:
1 year ago
Review Article
Author(s):
Mahmoud Izraiq
,
Nail Alshoubaki
,
Omran A Abu-Dhaim
,
et al
Added:
1 year ago
Management of CAD in TAVI
Author(s):
Cian Murray
,
Caoimhe Ryan
,
Michael Cronin
,
et al
Added:
11 months ago
Systematic Review
Coronary Calcification: Types, Morphology and Distribution
Author(s):
Michelle C Morris
,
Rolf P Kreutz
Added:
1 year ago
Review Article
Author(s):
Kevin Cheng
,
Jonathan M Hill
,
Ranil de Silva
Added:
1 year ago
Author(s):
Nicolas M Van Mieghem
Added:
1 week ago
EuroPCR 2026 — Professor Nicolas Van Mieghem joins us to discuss the FRACTURE trial, which evaluated the safety and effectiveness of the laser-based Seismic intravascular lithotripsy (IVL) system for the treatment of severely calcified coronary lesions.The FRACTURE trial was designed to support both FDA IDE and CE mark regulatory approval. It prospectively enrolled 440 patients, with a primary…
View more